364 filings
8-K
BCRX
Biocryst Pharmaceuticals Inc.
6 May 24
BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
7:03am
8-K
BCRX
Biocryst Pharmaceuticals Inc.
26 Feb 24
BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
7:05am
8-K
BCRX
Biocryst Pharmaceuticals Inc.
18 Jan 24
Amendments to Articles of Incorporation or Bylaws
5:21pm
8-K
BCRX
Biocryst Pharmaceuticals Inc.
8 Jan 24
Results of Operations and Financial Condition
7:02am
8-K
BCRX
Biocryst Pharmaceuticals Inc.
1 Dec 23
Departure of Directors or Certain Officers
7:37am
8-K
w484pgv
30 Nov 23
Regulation FD Disclosure
9:04am
8-K
wl4haj1q1lhvq7avzw5
3 Nov 23
Regulation FD Disclosure
12:16pm
8-K
bxq8f217jsi6xysd0yz
3 Nov 23
Regulation FD Disclosure
12:14pm
8-K
ldp4wkvehjx1lvq
2 Nov 23
BioCryst Reports Third Quarter 2023 Financial Results and Provides Business Update
7:05am
8-K
0z7ustny 8p
26 Oct 23
BioCryst Begins Enrollment in Proof-of-Concept Trial to Confirm Safe, Effective, Once-daily Dose of Oral Factor D Inhibitor, BCX10013
9:36am
8-K
fx9w m3cw7
3 Aug 23
BioCryst Reports Second Quarter 2023 Financial Results and Provides Business Update
7:04am
8-K
icioe1sebu
11 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
22g7c0jkz6 jjh0lrabm
14 Jun 23
Departure of Directors or Certain Officers
7:02am
8-K
zl2 4762p
3 May 23
BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update
7:08am
8-K
82is3q
18 Apr 23
Entry into a Material Definitive Agreement
7:02am
8-K
psxivzuln5iav3bjn
13 Mar 23
Regulation FD Disclosure
6:59am
8-K
xnmu 8r0k
21 Feb 23
BioCryst Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Key Milestones
7:05am
8-K
dvcozfis6qqfyz
9 Jan 23
BioCryst Announces Preliminary Full Year 2022 ORLADEYO® (berotralstat) Net Revenue and Provides Full Year 2023 ORLADEYO Net Revenue Guidance
7:10am
8-K
wlkshxokc5birmb3lc
15 Dec 22
BioCryst Discontinues Development of BCX9930 and Shifts Focus to Potential Once-daily, Oral Factor D Inhibitor, BCX10013
7:03am
8-K
00mw97n urmgtj6
1 Nov 22
BioCryst Reports Third Quarter 2022 Financial Results and Upcoming Key Milestones
7:06am